As of 2026-09-21, the Intrinsic Value of Cogent Biosciences Inc (COGT) is -11.04 USD. This COGT valuation is based on the model Peter Lynch Fair Value. With the current market price of 31.50 USD, the upside of Cogent Biosciences Inc is -135.04%.
Based on its market price of 31.50 USD and our intrinsic valuation, Cogent Biosciences Inc (COGT) is overvalued by 135.04%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -11.04 - -11.04 | -11.04 | -135.04% |
| P/E | (64.68) - (66.22) | (66.99) | -312.7% |
| DDM - Stable | (33.99) - (253.63) | (143.81) | -556.5% |
| DDM - Multi | (11.14) - (64.17) | (18.93) | -160.1% |
| Market Cap (mil) | 5,382.40 |
| Beta | 0.26 |
| Outstanding shares (mil) | 170.87 |
| Enterprise Value (mil) | 5,424.69 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.66% |
| Cost of Debt | 5.00% |
| WACC | 6.56% |